To Örebro University

oru.seÖrebro University Publications
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (10 of 361) Show all publications
Smith, K. A., Hiyoshi, A., Vingeliene, S., von Kobyletzki, L. B. & Montgomery, S. (2024). Atopic dermatitis and cognitive function: a sibling comparison study among males in Sweden [Letter to the editor]. British Journal of Dermatology, Article ID ljae004.
Open this publication in new window or tab >>Atopic dermatitis and cognitive function: a sibling comparison study among males in Sweden
Show others...
2024 (English)In: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, article id ljae004Article in journal, Letter (Refereed) Epub ahead of print
Abstract [en]

A previous study indicated that atopic dermatitis (AD) was associated with better cognitive function in males during late adolescence. This association was examined among 2 021 369 males who had a medical examination and cognitive function testing during a military conscription assessment in late adolescence in Sweden. Sibling-comparison analysis to tackle confounding indicated that AD is associated with poorer cognitive function, suggesting AD in childhood is detrimental for the development of cognitive function.

Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2024
National Category
Dermatology and Venereal Diseases
Identifiers
urn:nbn:se:oru:diva-110623 (URN)10.1093/bjd/ljae004 (DOI)001159796600001 ()38170455 (PubMedID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01236Nyckelfonden
Note

This study was supported by grants from the Swedish Research Council for Health, Working Life and Welfare (Forte) (grant number: 2019-01236), Nyckelfonden, and the UK Economic and Social Research Council (ESRC) to the International Centre for Life Course Studies (ES/R008930/1).

Available from: 2024-01-09 Created: 2024-01-09 Last updated: 2024-02-20Bibliographically approved
Arribas, C., Cavallaro, G., Gonzalez, J.-L., Lagares, C., Raffaeli, G., Smits, A., . . . Garrido, F. (2024). Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI). Pediatric Research
Open this publication in new window or tab >>Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI)
Show others...
2024 (English)In: Pediatric Research, ISSN 0031-3998, E-ISSN 1530-0447Article in journal (Refereed) Published
Abstract [en]

Background: There is variability in the use of sedatives and analgesics in neonatal intensive care units (NICUs). We aimed to investigate the use of analgesics and sedatives and the management of neonatal pain and distress.

Methods: This was a global, prospective, cross-sectional study. A survey was distributed May–November 2022. The primary outcome of this research was to compare results between countries depending on their socio-sanitary level using the sociodemographic index (SDI). We organized results based on geographical location.

Results: The survey collected 1304 responses, but we analyzed 924 responses after database cleaning. Responses from 98 different countries were analyzed. More than 60% of NICUs reported having an analgosedation guideline, and one-third of respondents used neonatal pain scales in more than 80% of neonates. We found differences in the management of sedation and analgesia between NICUs on different continents, but especially between countries with different SDIs. Countries with a higher SDI had greater availability of and adherence to analgosedation guidelines, as well as higher rates of analgosedation for painful or distressing procedures. Countries with different SDIs reported differences in analgosedation for neonatal intubation, invasive ventilation, and therapeutic hypothermia, among others.

Conclusions: Socio-economic status of countries impacts on neonatal analgosedation management.

Keywords
Newborn infant, pain, survey
National Category
Pediatrics
Identifiers
urn:nbn:se:oru:diva-111609 (URN)10.1038/s41390-024-03032-7 (DOI)
Available from: 2024-02-15 Created: 2024-02-15 Last updated: 2024-02-19Bibliographically approved
Vingeliene, S., Hiyoshi, A., Lentjes, M., Fall, K. & Montgomery, S. (2023). Ageing accounts for much of the association between decreasing grip strength and subsequent loneliness: the English Longitudinal Study of Ageing. Journal of Epidemiology and Community Health, 77(3), 175-181
Open this publication in new window or tab >>Ageing accounts for much of the association between decreasing grip strength and subsequent loneliness: the English Longitudinal Study of Ageing
Show others...
2023 (English)In: Journal of Epidemiology and Community Health, ISSN 0143-005X, E-ISSN 1470-2738, Vol. 77, no 3, p. 175-181Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Loneliness at older ages has been associated with higher morbidity and mortality. One of the risk factors for loneliness may be age-related decline in skeletal muscle strength, which may limit the possibilities for engagement in usual social activities and maintaining relationships. We aimed to identify if decrease in grip strength is an independent determinant of subsequent change in loneliness.

METHODS: Prospective cohort study of participants aged 50 years or older living in private households and provided data in the English Longitudinal Study of Ageing waves 2 (2004/2005), 4 (2008/2009) and 6 (2012/2013) (n=6118). We used fixed effects linear models to estimate β coefficients and 95% confidence intervals.

RESULTS: The adjusted estimates for a 5-kilogramme decrease in grip strength and loneliness score (ranging from 3 to 9) are β 0.04 and 95% CI -0.003 to 0.08 among men and β 0.03 and 95% CI -0.02 to 0.09 among women. In age-stratified analysis, a statistically significant association was observed among men below the age of 80 years (0.04, 0.0001 to 0.08) but not among older men (0.04, -0.28 to 0.35), and among women below the age of 80 years (0.03, -0.002 to 0.09) or above (-0.02, -0.32 to 0.28).

CONCLUSION: Muscle strength declines with age and may help explain the greater social isolation that occurs at older ages. Decline in strength was only independently associated with modestly increased loneliness among men younger than 80 years of age, indicating its limitation as a potential marker of loneliness risk.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
Aging, epidemiology, gerontology, longitudinal studies, public health
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:oru:diva-97904 (URN)10.1136/jech-2021-218635 (DOI)000766735700001 ()35256526 (PubMedID)2-s2.0-85142665246 (Scopus ID)
Note

Funding agency:

Orebro University doctoral studentship MV3028

Available from: 2022-03-09 Created: 2022-03-09 Last updated: 2023-12-08Bibliographically approved
Garcia-Argibay, M., Hiyoshi, A. & Montgomery, S. (2023). Association between dementia risk and ulcerative colitis, with and without colectomy: a Swedish population-based register study. BMJ Open, 13(12), Article ID e074110.
Open this publication in new window or tab >>Association between dementia risk and ulcerative colitis, with and without colectomy: a Swedish population-based register study
2023 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 13, no 12, article id e074110Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: This study aims to investigate the association of ulcerative colitis (UC) with all-cause dementia and assess differences in those with and without a total colectomy.

DESIGN, SETTING AND PARTICIPANTS: This Swedish prospective register-based study comprised 4.8 million individuals aged at least 59 years between 1964 and 2018 with the linkage of several Swedish national registers.

PRIMARY AND SECONDARY OUTCOME MEASURES: Individuals with dementia were defined according to International Classification of Diseases diagnostic codes and Anatomical Therapeutic Classification codes for medication prescriptions. Fitting Cox hazards models, the risk of developing all-cause dementia in individuals with and without UC was estimated. Further, we compared the risk of all-cause dementia among those with and without a colectomy.

RESULTS: Among 4 821 488 individuals (52.6% females) followed for 84.1 million person-years between 1964 and 2018, the incidence rate of all-cause dementia was 63.90 (63.73-64.07) events per 10 000 person-years in individuals without UC, 94.80 (92.04-97.64) among those with UC, 95.01 (92.25-97.86) in those with UC but without colectomy and 63.42 (40.92-98.31) in those with UC and a colectomy. Adjusted Cox models showed an increased all-cause dementia risk in individuals with UC (HR 1.07, 95% CI 1.04 to 1.10). We found no differences between unexposed individuals and those with UC and a colectomy (HR 0.89, 95% CI 0.57 to 1.38).

CONCLUSION: The findings are consistent with previous evidence suggesting a slightly increased dementia risk among individuals with UC. This study provided no evidence of further risk increase of dementia among those who had a colectomy.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
Epidemiology, gastroenterology, inflammatory bowel disease
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:oru:diva-110543 (URN)10.1136/bmjopen-2023-074110 (DOI)001134943800093 ()38135306 (PubMedID)2-s2.0-85181177014 (Scopus ID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01236
Available from: 2023-12-23 Created: 2023-12-23 Last updated: 2024-02-27Bibliographically approved
Vingeliene, S., Hiyoshi, A., Carlberg, M., Garcia-Argibay, M., Lentjes, M., Fall, K., . . . Montgomery, S. (2023). Atopic dermatitis, systemic inflammation and subsequent dementia risk. JEADV Clinical Practice, 2(4), 839-848
Open this publication in new window or tab >>Atopic dermatitis, systemic inflammation and subsequent dementia risk
Show others...
2023 (English)In: JEADV Clinical Practice, E-ISSN 2768-6566, Vol. 2, no 4, p. 839-848Article in journal (Refereed) Published
Abstract [en]

Background: Atopic dermatitis is a chronic inflammatory skin disease and inflammation has been implicated in development of other chronic diseases, but few studies have examined the relationship with dementia.

Objectives: This study examines associations of atopic dermatitis (AD) and systemic inflammation in adolescence measured using erythrocyte sedimenta-tion rate (ESR), as well as AD diagnosed in adulthood, with dementia risk.

Methods: We used three Swedish register‐based cohorts. Cohort I (N= 795,680) comprised men, born in 1951–1968, who participated in themilitary conscription examinations with physician‐assessed AD and ESR; Cohort II (N= 1,757,600) included men and women, born in 1951–1968; and Cohort III (N= 3,988,783) included all individuals in Sweden, born in 1930–1968. We used Cox regression, estimating hazard ratios (HR), with thefollow‐up from 50 years of age to dementia diagnosis, date of emigration, death, or 31 December 2018, which ever occurred first. Further, we used asibling comparison design to adjust for unmeasured confounders shared among siblings.

Results: Cohort I: 1466 dementia events were accrued during follow‐up of 7.8 years, with a crude rate of 21.6 [95% confidence interval (CI): 20.6, 22.8] per 100,000 person‐years. Cohort II: 3549 dementia events were accrued duringfollow‐up of 7.4 years, with a crude rate of 23.7 (95% CI: 22.9, 24.5) per 100,000 person‐years. Cohort III: 120,303 dementia events were accrued during follow‐up of 23.7 years, with a crude rate of 180.3 (95% CI: 179.3, 181.3) per 100,000 person‐years. In multivariable analysis using Cohort I, there was no association between AD and dementia [HR 0.68 (95% CI 0.32, 1.43)], norwith moderate [HR 0.71 (95% CI: 0.46, 1.10)] or high [HR 1.23 (95% CI: 0.87, 1.75)] ESR. AD was not associated with dementia risk in Cohort II [HR 1.28(0.97, 1.71)] or Cohort III [HR 1.01 (0.92, 1.11)].

Conclusions: AD was not associated with dementia risk, neither was systemic inflammation measured by ESR in adolescence.

Keywords
Atopic dermatitis, dementia, erythrocyte sedimentation rate
National Category
Dermatology and Venereal Diseases
Research subject
Dermatology and Venerology
Identifiers
urn:nbn:se:oru:diva-108570 (URN)10.1002/jvc2.249 (DOI)2-s2.0-85181467049 (Scopus ID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2019‐01236The Kamprad Family Foundation
Available from: 2023-09-26 Created: 2023-09-26 Last updated: 2024-01-12Bibliographically approved
Hiyoshi, A., Rostila, M., Fall, K., Montgomery, S. & Grotta, A. (2023). Caregiving and changes in health-related behaviour. Social Science and Medicine, 322, Article ID 115830.
Open this publication in new window or tab >>Caregiving and changes in health-related behaviour
Show others...
2023 (English)In: Social Science and Medicine, ISSN 0277-9536, E-ISSN 1873-5347, Vol. 322, article id 115830Article in journal (Refereed) Published
Abstract [en]

Potential health risks for informal caregivers have been hypothesised to be partly related to adverse changes in health-related behaviour, but evidence is limited. We examined whether smoking, drinking, eating, physical activity or leisure pursuits change in relation to co-resident or out-of-home caregiving (for someone outside the household), and if associations differ by sex, educational attainment, and welfare state typology. We conducted a longitudinal study using six waves of the Survey of Health, Ageing and Retirement in Europe, collecting data repeatedly from 2004 to 2017 for adults aged 50 years and older living in 17 European countries (57,962 individuals). To control for measured and unmeasured within-individual time-invariant confounders, we used fixed effects logistic models to analyse the repeated measures of caregiving, behaviour and covariates and estimated odds ratios (OR) with 95% confidence intervals (95%CI). Among male participants, unhealthy eating increased while smoking decreased [ORs 1.26 (95%CI 1.01-1.58) and 0.53 (0.36-0.78), respectively] in survey waves in which they provided co-resident care, compared with the waves that they did not. Among female participants, there was little change in behaviour between waves with and without co-resident caregiving. When providing out-of-home care, lacks of physical activity and leisure pursuits declined. But in the same time, drinking increased both men and women, and especially among individuals with lower educational attainment and residing in non-Nordic countries. To conclude, overall, increased drinking when providing out-of-home care was most consistent, especially among individuals with lower educational attainment and residing in non-Nordic countries. Otherwise, the associations varied by the type of care, behaviour and population subgroups. These findings indicated that not all caregivers are susceptible to behavioural changes, and that not all behaviour may be involved similarly in linking caregiving to health risks. This opens possibilities to target specific behaviour and groups to prevent adverse changes in health behaviour in caregivers.

Place, publisher, year, edition, pages
Elsevier, 2023
Keywords
Caregivers, Education, Europe, Fixed effects models, Health behaviour, Longitudinal studies, Sex, Welfare state
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:oru:diva-105097 (URN)10.1016/j.socscimed.2023.115830 (DOI)000972618500001 ()36930838 (PubMedID)2-s2.0-85150075819 (Scopus ID)
Funder
Swedish Research Council, 2017-03266Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01236 2021-00676
Note

Funding agency:

Osaka University International Joint Research Promotion Programme (Type A) 2019-2022

General Electric

Available from: 2023-03-20 Created: 2023-03-20 Last updated: 2023-05-09Bibliographically approved
Fadl, H., Saeedi, M., Magnuson, A., Patil, S., Simmons, D., Schwarcz, E., . . . Montgomery, S. (2023). Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: a stepped wedge cluster randomised controlled trial. In: : . Paper presented at 55th DPSG annual meeting 2023, Poznan, Polen, 7-10 September, 2023.. (1)
Open this publication in new window or tab >>Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: a stepped wedge cluster randomised controlled trial
Show others...
2023 (English)Conference paper, Oral presentation only (Other academic)
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:oru:diva-109825 (URN)
Conference
55th DPSG annual meeting 2023, Poznan, Polen, 7-10 September, 2023.
Available from: 2023-11-22 Created: 2023-11-22 Last updated: 2024-01-02Bibliographically approved
Giezeman, M., Sundh, J., Athlin, Å., Lisspers, K., Ställberg, B., Janson, C., . . . Hasselgren, M. (2023). Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality: A 15-Year Follow-Up. The International Journal of Chronic Obstructive Pulmonary Disease, 18, 11-21
Open this publication in new window or tab >>Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality: A 15-Year Follow-Up
Show others...
2023 (English)In: The International Journal of Chronic Obstructive Pulmonary Disease, ISSN 1176-9106, E-ISSN 1178-2005, Vol. 18, p. 11-21Article in journal (Refereed) Published
Abstract [en]

PURPOSE: The aim of this study was to examine the association of comorbid heart disease, defined as chronic heart failure or ischemic heart disease, on all-cause and cause-specific hospitalization and mortality in patients with COPD over a period of nearly 15 years.

MATERIALS AND METHODS: The cohort study included patients with COPD from primary and secondary care in 2005 with data from questionnaires and medical record reviews. The Swedish Board of Health and Welfare provided hospitalization and mortality data from 2005 through 2019. Cox regression analyses, adjusted for sex, age, educational level, smoking status, BMI, exacerbations, dyspnea score and comorbid diabetes or hypertension, assessed the association of comorbid heart disease with all-cause and cause-specific time to first hospitalization and death. Linear regression analyses, adjusted for the same variables, assessed this association with hospitalization days per year for those patients that had been hospitalized.

RESULTS: Of the 1071 patients, 262 (25%) had heart disease at baseline. Cox regression analysis showed a higher risk of hospitalization for patients with heart disease for all-cause (HR (95% CI) 1.55; 1.32-1.82), cardiovascular (2.14; 1.70-2.70) and other causes (1.27; 1.06-1.52). Patients with heart disease also had an increased risk of all-cause (1.77; 1.48-2.12), cardiovascular (3.40; 2.41-4.78) and other (1.50; 1.09-2.06) mortality. Heart disease was significantly associated with more hospitalization days per year of all-cause (regression coefficient 0.37; 95% CI 0.15-0.59), cardiovascular (0.57; 0.27-0.86) and other (0.37; 0.12-0.62) causes. No significant associations were found between heart disease and respiratory causes of hospitalization and death.

CONCLUSION: Comorbid heart disease in patients with COPD is associated with an increased risk for all-cause hospitalization and mortality, mainly due to an increase of hospitalization and death of cardiovascular and other causes, but not because of respiratory disease. This finding advocates the need of a strong clinical focus on primary and secondary prevention of cardiovascular disease in patients with COPD.

Place, publisher, year, edition, pages
Dove Medical Press Ltd., 2023
Keywords
Chronic heart failure, chronic obstructive pulmonary disease, comorbidity, hospitalization, ischemic heart disease, mortality
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:oru:diva-103309 (URN)10.2147/COPD.S378979 (DOI)000994341900001 ()36644219 (PubMedID)2-s2.0-85146313479 (Scopus ID)
Funder
Region VärmlandRegion Örebro CountyBror Hjerpstedts stiftelse
Available from: 2023-01-23 Created: 2023-01-23 Last updated: 2024-01-03Bibliographically approved
Cao, Y., Forssten, M. P., Sarani, B., Montgomery, S. & Mohseni, S. (2023). Development and Validation of an XGBoost-Algorithm-Powered Survival Model for Predicting In-Hospital Mortality Based on 545,388 Isolated Severe Traumatic Brain Injury Patients from the TQIP Database. Journal of Personalized Medicine, 13(9), Article ID 1401.
Open this publication in new window or tab >>Development and Validation of an XGBoost-Algorithm-Powered Survival Model for Predicting In-Hospital Mortality Based on 545,388 Isolated Severe Traumatic Brain Injury Patients from the TQIP Database
Show others...
2023 (English)In: Journal of Personalized Medicine, E-ISSN 2075-4426, Vol. 13, no 9, article id 1401Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Traumatic brain injury (TBI) represents a significant global health issue; the traditional tools such as the Glasgow Coma Scale (GCS) and Abbreviated Injury Scale (AIS) which have been used for injury severity grading, struggle to capture outcomes after TBI.

AIM AND METHODS: This paper aims to implement extreme gradient boosting (XGBoost), a powerful machine learning algorithm that combines the predictions of multiple weak models to create a strong predictive model with high accuracy and efficiency, in order to develop and validate a predictive model for in-hospital mortality in patients with isolated severe traumatic brain injury and to identify the most influential predictors. In total, 545,388 patients from the 2013-2021 American College of Surgeons Trauma Quality Improvement Program (TQIP) database were included in the current study, with 80% of the patients used for model training and 20% of the patients for the final model test. The primary outcome of the study was in-hospital mortality. Predictors were patients' demographics, admission status, as well as comorbidities, and clinical characteristics. Penalized Cox regression models were used to investigate the associations between the survival outcomes and the predictors and select the best predictors. An extreme gradient boosting (XGBoost)-powered Cox regression model was then used to predict the survival outcome. The performance of the models was evaluated using the Harrell's concordance index (C-index). The time-dependent area under the receiver operating characteristic curve (AUC) was used to evaluate the dynamic cumulative performance of the models. The importance of the predictors in the final prediction model was evaluated using the Shapley additive explanations (SHAP) value.

RESULTS: On average, the final XGBoost-powered Cox regression model performed at an acceptable level for patients with a length of stay up to 250 days (mean time-dependent AUC = 0.713) in the test dataset. However, for patients with a length of stay between 20 and 213 days, the performance of the model was relatively poor (time-dependent AUC < 0.7). When limited to patients with a length of stay ≤20 days, which accounts for 95.4% of all the patients, the model achieved an excellent performance (mean time-dependent AUC = 0.813). When further limited to patients with a length of stay ≤5 days, which accounts for two-thirds of all the patients, the model achieved an outstanding performance (mean time-dependent AUC = 0.917).

CONCLUSION: The XGBoost-powered Cox regression model can achieve an outstanding predictive ability for in-hospital mortality during the first 5 days, primarily based on the severity of the injury, the GCS on admission, and the patient's age. These variables continue to demonstrate an excellent predictive ability up to 20 days after admission, a period of care that accounts for over 95% of severe TBI patients. Past 20 days of care, other factors appear to be the primary drivers of in-hospital mortality, indicating a potential window of opportunity for improving outcomes.

Place, publisher, year, edition, pages
MDPI, 2023
Keywords
Trauma Quality Improvement Program (TQIP), extreme gradient boosting (XGBoost), machine learning, prediction model, survival analysis, traumatic brain injury
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-108668 (URN)10.3390/jpm13091401 (DOI)001082963300001 ()37763168 (PubMedID)2-s2.0-85172865755 (Scopus ID)
Available from: 2023-10-02 Created: 2023-10-02 Last updated: 2024-03-06Bibliographically approved
Athlin, Å., Lisspers, K., Hasselgren, M., Ställberg, B., Janson, C., Montgomery, S., . . . Sundh, J. (2023). Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. npj Primary Care Respiratory Medicine, 33(1), Article ID 23.
Open this publication in new window or tab >>Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts
Show others...
2023 (English)In: npj Primary Care Respiratory Medicine, E-ISSN 2055-1010, Vol. 33, no 1, article id 23Article in journal (Refereed) Published
Abstract [en]

Spirometry should be used to confirm a diagnosis of chronic obstructive pulmonary disease (COPD). This test is not always performed, leading to possible misdiagnosis. We investigated whether the proportion of patients with diagnostic spirometry has increased over time as well as factors associated with omitted or incorrectly interpreted spirometry. Data from medical reviews and a questionnaire from primary and secondary care patients with a doctors' diagnosis of COPD between 2004 and 2010 were collected. Data were compared with a COPD cohort diagnosed between 2000 and 2003. Among 703 patients with a first diagnosis of COPD between 2004 and 2010, 88% had a diagnostic spirometry, compared with 59% (p < 0.001) in the previous cohort. Factors associated with not having diagnostic spirometry were current smoking (OR 2.21; 95% CI 1.36-3.60), low educational level (OR 1.81; 1.09-3.02) and management in primary care (OR 2.28; 1.02-5.14). The correct interpretation of spirometry results increased (75% vs 82%; p = 0.010). Among patients with a repeated spirometry, 94% had a persistent FEV1/FVC or FEV1/VC ratio <0.70.

Place, publisher, year, edition, pages
Nature Publishing Group, 2023
National Category
Respiratory Medicine and Allergy
Identifiers
urn:nbn:se:oru:diva-106171 (URN)10.1038/s41533-023-00345-8 (DOI)000999605900001 ()37264017 (PubMedID)2-s2.0-85160925109 (Scopus ID)
Funder
Bror Hjerpstedts stiftelse
Note

Funding agency:

Uppsala County Association Against Heart and Lung Diseases

Available from: 2023-06-02 Created: 2023-06-02 Last updated: 2024-01-03Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-6328-5494

Search in DiVA

Show all publications